Cantor Fitzgerald Equities Analysts Lower Earnings Estimates for Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – Research analysts at Cantor Fitzgerald lowered their FY2023 earnings per share estimates for shares of Longboard Pharmaceuticals in a research note issued to investors on Monday, August 7th. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will earn ($2.33) per share for the year, down […]

Related Keywords

,Cantor Fitzgerald ,Health Asset Management ,News Ratings For Longboard Pharmaceuticals Daily ,Blackrock Inc ,Asset Management Inc ,Bourgeon Capital Management ,Longboard Pharmaceuticals ,Nasdaq ,Longboard Pharmaceuticals Trading ,Longboard Pharmaceuticals Inc ,Free Report ,Longboard Pharmaceutical ,Get Free Report ,Capital Management ,Management Inc ,Longboard Pharmaceuticals Daily ,Nasdaq Lbph ,Lbph ,Medical ,Earnings Estimates ,